Sonic Healthcare USA

Managed Markets refers to the segment of the U.S. Healthcare and Pharmaceutical industry focused on the management, distribution and reimbursement of healthcare products and services in a complex and evolving ecosystem. Managed Markets specifically influence how therapies reach patients, the speed of adoption, and the cost-effectiveness of care. By coordinating stakeholders and leveraging data-driven strategies, Managed Markets aim to improve patient outcomes, optimize drug utilization, and control healthcare spending. Quality Assurance and Regulatory Compliance are also integral throughout each step of the process.

Payers, providers, and manufacturers (e.g., drugs, devices, Durable Medical Equipment, etc.) collaborate to ensure cost-effective, accessible, and streamlined healthcare delivery. In recent years, more payers are also engaging in warranty and value-based contracting, especially for high-cost cell and gene therapies.

Key stakeholders in Managed Markets include:

1) Payors, which are organizations that finance or reimburse the cost of health services. Examples include: Private Insurance companies (e.g., Blue Cross Blue Shield, United Healthcare, Aetna or similar), Government Programs (e.g., Medicare Medicaid, Veterans Affairs, etc.) and Pharmacy Benefit Managers (PBMs).

2) Providers are healthcare professionals and facilities delivering care, including physicians, hospitals, pharmacies, Home Health Aids, Physical, Occupational, and Speech Therapy, Mental Health Professionals, Rehab facilities (various types), and Long-Term Care.

3) Employers may pay a portion of an employees’ Monthly Premium under an insurance Group Plan or even pay employees health claims with their own pool of money (aka. Self-Insured), which saves on Premium expenses and is either managed by employees or 3rd Party Administrators. The Self-Insured solution is also common for Workers Compensation, which is another payor involved to cover healthcare costs due to employee work-related injuries.

4) Patients are the ultimate consumers and beneficiaries of healthcare services and products. Continuous value-delivery will lead to more positive outcomes and better overall health.

Managed Markets Core Components include:

1) Formulary Management comprised of lists of covered drugs and treatments based on cost, efficacy, “Evidence-Based” clinical guidelines, and “Peer-Reviewed” literature.

2) Reimbursement policies to determine how healthcare services and products are paid for by payors and ensure compliance with Federal and State regulations (e.g., HIPAA, AHRQ, FDA, Joint Commission Standards, CLIA, etc.). Examples of reimbursement policies include insurance coverage (aka. Allowed Amounts), Co-Insurance, Copayments, and Prior-Authorization requirements.

"By coordinating stakeholders and leveraging data-driven strategies, managed markets aim to improve patient outcomes, optimize drug utilization, and control healthcare spending."

A Fee-Schedule in Medical Billing is a detailed list showing the maximum amount a healthcare provider will be paid by an insurance company for specific medical services and procedures. Each service or procedure gets a unique code, usually standardized by the Current Procedural Terminology (CPT) or the Healthcare Common Procedure Coding System (HCPCS). These codes ensure consistency and accuracy in billing and reimbursement processes.

The steps to effectively create a Fee-Schedule are:

1) Data Collection on healthcare services, including the cost of delivering these services, regional cost differences and historical billing information.

2) CPT, HCPCS, PLA or other code assignment that describes the procedure and service in detail.

3) Relative Value Units (RVUs), which is the Centers for Medicare & Medicaid Services (CMS) solution to determine the relative cost of services and considers physician’s work, practice expenses and malpractice insurance costs.

4) Conversion Factor, which is a monetary amount used to convert RVUs into actual payment amounts that can change annually based on economic factors and policy updates.

Fee-Schedules are regularly updated (usually annually) to reflect changes in medical practice, technology and economic conditions. Updates also address discrepancies and ensure the schedule remains fair and accurate. CMS develops Fee-Schedules for physicians, Ambulance services, Clinical Laboratory services, and Durable Medical Equipment (DME), such as prosthetics, orthotics, and supplies. Commercial Payors (may or may not be an insurance plan) in the United States often use Medicare Fee-Schedules as a basis for reimbursement for identical or similar health services.

Value-Based Contracting comprises agreements between payors and manufacturers tying reimbursement to clinical and economic outcomes. There are also proven strategies to ensure patients can afford and access necessary treatments. For example, cost-containment comprises efforts to control healthcare costs while maintaining or improving quality, such as Prior-Authorization, tiered formularies, or step therapy.

Health Economics and Outcomes Research (HEOR) studies cost-effectiveness, treatment value, and patient outcomes to inform decisions. And Pharmacoeconomics, a branch of Health Economics, helps identify, measure, and compare the costs and outcomes of pharmaceutical products and services (e.g., Drug Therapy) to help shape clinical decisions and guide optimal healthcare resource allocation in a standardized and scientifically grounded manner. Pharmaceutical companies also interact with various other Managed Markets stakeholders to deliver value to patients and other impacted stakeholders.

Reimbursement or Revenue Cycle Management in healthcare also ensures providers receive timely and accurate compensation for their services. Key components/activities include:

1) Patient Registration to capture all patient data required for accurate billing and reporting.

2) Insurance Verification to avoid claim denials.

3) Medical Coding or translating clinical documentation into standardized codes for billing and claims submission.

4) Charge Entry or inputting coded information into billing systems.

5) Timely and accurate Claims Submission to insurance providers, typically electronically (e.g., EDI or Web-Service format) through Revenue Cycle Management Systems. Sometimes Clearinghouses or other middleware solutions are also used to correct claims prior-to submission.

6) Posting of payments received.

7) Denial Management to improve reimbursement. 8) Collecting remaining payments due for any remaining balances.

8) Collecting remaining payments due for any remaining balances.

Throughout the entire clinical treatment and associated reimbursement processes, positive outcomes and value-delivery are dependent on timely and effective stakeholder collaboration, adoption, and use of appropriate, high-quality, evidence-based tools and clinical services, also efficient and effective front and back-end administrative processes.